Add BrightSurf on Google Email

The Lancet


Risk with assisted fertilization births could be due to infertility causes rather than procedure

A recent study found that infants conceived through assisted fertilization had similar birth weights and gestational ages as those conceived naturally. However, they were more likely to experience perinatal deaths if their mother had previously struggled with infertility. The researchers suggest that the underlying causes of infertilit...

SourceThe Lancet_DELETED·JournalThe Lancet·DateJul 30, 2008

HIV/AIDS in Latin America and the Caribbean

The HIV/AIDS epidemic affects nearly 2 million people in Latin America and the Caribbean, with most transmission through unprotected sex. The region faces unique challenges due to socio-economic disparities, homophobia, and lack of access to healthcare and education.

SourceThe Lancet_DELETED·JournalThe Lancet·DateJul 24, 2008

New drugs for Crohn's disease

Researchers are developing new treatments targeting Crohn's disease by blocking autoimmune responses and strengthening the intestinal lining. The goal is to provide more effective options for patients who have lost response to current treatments.

SourceThe Lancet_DELETED·JournalThe Lancet·DateJul 3, 2008

Gender is an issue in kidney transplantation

A retrospective cohort study found complex gender interactions in kidney transplantation outcomes, with female donors having a higher rate of graft loss and female recipients experiencing a lower rate of graft failure. The study suggests considering sex in future studies and decisions on organ allocation to optimize transplant success.

SourceThe Lancet_DELETED·JournalThe Lancet·DateJul 3, 2008

Monitoring of biological markers of passive smoking key to establishing level of cancer risk

Research suggests that passive smoking poses a significant risk to lung cancer development, with sidestream smoke potentially more carcinogenic than mainstream smoke. The study proposes using DNA-lesion footprinting and mutagenicity analysis to identify unique biological markers for assessing lung cancer risk in relation to SHS exposure.

SourceThe Lancet_DELETED·JournalThe Lancet Oncology·DateJul 1, 2008